US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

CORRECTDOSE Children's ALLERGY RELIEF

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 62320-302-05 D-1492-2022
Class II · Moderate risk Terminated

GUAIFENESIN AND DEXTROMETHORPHAN 200-20 mg/10 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6980-72 D-1491-2022
Class II · Moderate risk Terminated

GUAIFENESIN AND DEXTROMETHORPHAN 100 mg-10 mg/5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6844-70 D-1490-2022
Class II · Moderate risk Terminated

Diphenhydramine HCl Oral Solution

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6741-72 D-1489-2022
Class II · Moderate risk Terminated

Diphenhydramine HCl Oral Solution 12.5 mg / 5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6740-70 D-1488-2022
Class II · Moderate risk Terminated

Calcium Carbonate Oral Suspension

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-7098-94 D-1487-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution 650 mg / 20.3 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6820-76 D-1486-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6739-71 D-1485-2022
Class II · Moderate risk Terminated

Acetaminophen Oral Solution 160 mg / 5 mL

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6738-70 D-1484-2022
Class II · Moderate risk Terminated

Magnesium Hydroxide 2400 mg

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6839-73 D-1483-2022
Class II · Moderate risk Terminated

Magnesium Hydroxide 1200 mg

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6838-73 D-1482-2022
Class II · Moderate risk Terminated

Milk of Magnesia USP

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6840-72 D-1481-2022
Class II · Moderate risk Terminated

Milk of Magnesia USP

Reason CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Plastikon Healthcare LLC NDC 0904-6846-73 D-1480-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-165-90 D-1163-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-164-90 D-1162-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

PD-Rx Pharmaceuticals, Inc. NDC 72789-163-90 D-1161-2022
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.

Sun Pharmaceutical Industries INC NDC 62756-015-40 D-1176-2022
Class II · Moderate risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Failed Tablet/Capsule Specification; oversized tablet found in a bottle

Sun Pharmaceutical Industries INC NDC 57664-783-68 D-1155-2022
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

Sun Pharmaceutical Industries INC NDC 62756-015-40 D-1153-2022
Class II · Moderate risk Terminated

Earache Drops

Reason Microbial contamination of non-sterile product.

Grato Holdings, Inc. NDC 0363-3233-15 D-0991-2022
Class II · Moderate risk Terminated

Homeopathic EarAche Ear Drops

Reason Microbial contamination of non-sterile product.

Grato Holdings, Inc. NDC 59779-568-15 D-0990-2022
Class II · Moderate risk Terminated

Homeopathic EarAche Drops

Reason Microbial contamination of non-sterile product.

Grato Holdings, Inc. NDC 11822-3644-3 D-0989-2022
Class II · Moderate risk Terminated

B-Complex + Chromic Chloride

Reason Lack of Assurance of Sterility

US Specialty Formulations LLC D-0987-2022
Class II · Moderate risk Terminated

Ethanol for Injection 95%

Reason Lack of Assurance of Sterility

US Specialty Formulations LLC D-0986-2022
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Strides Pharma Inc. NDC 64380-935-05 D-0974-2022